Tanasi Launches University-Developed, Full-Spectrum Cannabinoid Product Line

GreenWay Herbal Products announced Thursday the launch of Tanasi, a university-developed cannabis full-spectrum product line using a patent-pending CBDA/CBD formula.

“The CBDA is present in the raw plant material, and is the acidic precursor to CBD. The combination of CBDA/CBD is the basis, and difference maker, of our Tanasi product line. Two compounds work better than one, and we believe our products work better than CBD alone,” CEO Jeff Heeren said in a press release.

The entire Tanasi CBD patent-pending line contains 0.3% THC or less. All products are non-psychoactive and third-party tested.

Get Started

Earn 7.2% — No Matter What the Fed Does

Markets expect rate cuts — but your earnings don’t have to suffer. Lock in 7.2% until 2028 from ten individual bonds.

Get Started

The Entire line includes:

• Tinctures: Hemp extract from Cannabis Sativa L. CBDA/CBD formula, cannabinoids, and terpenes, combined with MCT oil.
• Capsules: Vegan HPMC capsules containing hemp extract from Cannabis Sativa L. that contains CBDA/CBD formula, cannabinoids, and terpenes, combined with MCT oil and sunflower oil.
• Lotion & Salve: both water and oil based

GreenWay Herbal Products declared activities related to its 10-year, $2.5 million university-licensing research agreement.